BioCentury
ARTICLE | Clinical News

Oncolin preclinical data

April 21, 2008 7:00 AM UTC

In mice with implanted human brain tumors, ONC-127 plus Temodar temozolomide produced better survival and anti-tumor activity vs. either agent alone. Monotherapy with ONC-127, a glycolysis inhibitor,...